Home › Akorn Reaffirms 2015 Revenue and EPS Guidance
 

Keywords :   


Akorn Reaffirms 2015 Revenue and EPS Guidance

2015-03-10 16:40:35| Biotech - Topix.net

Akorn, Inc. reaffirms its 2015 EPS metrics issued on February 26, 2015 calling for revenue of between $960 million and $980 million and adjusted diluted earnings per share of between $1.88 and $1.98. Akorn's Chief Financial Officer Tim Dick will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 10:15 a.m. EDT at the Loews Miami Beach Hotel in Miami Beach, Florida.

Tags: revenue guidance eps reaffirms

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
03.07Greece starts six-day working week for some industries
03.07ThaMa-Vet unveils fixed dosage swine syringes
03.07Hurricane Beryl Graphics
03.07Farm Progress America, July 3, 2024
03.07Farm Progress America, July 3, 2024
03.07Digital video subscriptions to reach 3.5 billion by 2028
03.07Hurricane Beryl Forecast Discussion Number 19
03.07Hurricane Beryl Wind Speed Probabilities Number 19
More »